New Genetic Variants in Thyroid Function Identified
A team of researchers investigated the influence of genetic variation on thyroid hormone concentrations.
A team of researchers investigated the influence of genetic variation on thyroid hormone concentrations.
Investigators report on a case series of patients who experienced new onset or relapsed Graves disease-related hyperthyroidism following undergoing vaccination for COVID-19.
A team of investigators sought to determine the prevalence of thyroid disorders in patients with atrial fibrillation.
Diabetes and thyroid disease often coexist in patients with the disorders, but the connection between new onset diabetes with thyroid dysfunction is unclear. Investigators looked for the link.
Graves disease can alter the medial temporal lobe. Researchers sought to observe whether therapeutic interventions could restore normal brain structure.
Graves hyperthyroidism has a remission rate of 20%-30% with standard antithyroid drug treatment, but long-term use can be problematic. Researchers explored whether adjuvant rituximab would aid remission rates.
Researchers have developed a machine learning tool to predict which patients with hyperthyroidism are at risk of developing thyrotoxic atrial fibrillation.
Investigators say the discovery of the role of the CD160/HVEM/LIGHT/BTLA pathway in Graves disease adds new data to the genetic contribution to disease susceptibility.
Researchers sought to determine the relationship between thyroid hormone treatment intensity and the incidence of atrial fibrillation and stroke.
Researchers investigated thyroid function in women 6 months postpartum relative to maternal iodine, selenium, and iron status.